cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ignyta Inc
1 own
6 watching
Current Price
$114.47
$-4.64
(-3.9%)
logo-rxdx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,790M
52-Week High
52-Week High
122.75
52-Week Low
52-Week Low
21.5
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
-2.97577855
iconMarket Capitalization4,790M
icon52-Week High122.75
icon52-Week Low21.5
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio-2.97577855
What does the Ignyta Inc do?
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn s disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR600, an anti-tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; PR1800, an anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California.
Read More
How much money does Ignyta Inc make?
News & Events about Ignyta Inc.
Zolmax
5days ago
Prometheus Biosciences, Inc. (NASDAQ:RXDX Get Rating) CEO Mark C. Mckenna sold 25,000 shares of the stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $118.99, for a total value of $2,974,750.00. Following the transaction, the chief executive officer now ...
Globe Newswire
24days ago
SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc.(Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of ...
Globe Newswire
1month ago
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX),a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of ...
PR Newswire
1month ago
Thinking about trading options or stock in Prometheus Biosciences, Apple, Chevron, DexCom, or Amazon? Thinking about trading options or stock in Prometheus Biosciences, Apple, Chevron, DexCom, or Amazon? PR Newswire NEW YORK, Dec. 8, 2022 NEW YORK, Dec. 8, 2022 /PRNewswire...
PR Newswire
1month ago
Thinking about buying stock in Prometheus Biosciences, Meta Materials, Eterna Therapeutics, Roivant Sciences, or China Automotive Systems? Thinking about buying stock in Prometheus Biosciences, Meta Materials, Eterna Therapeutics, Roivant Sciences, or China Automotive Systems? PR Newswire NEW YORK...
Frequently Asked Questions
Frequently Asked Questions
What is Ignyta Inc share price today?
plus_minus_icon
Can Indians buy Ignyta Inc shares?
plus_minus_icon
How can I buy Ignyta Inc shares from India?
plus_minus_icon
Can Fractional shares of Ignyta Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ignyta Inc stocks?
plus_minus_icon
What is today’s traded volume of Ignyta Inc?
plus_minus_icon
What is today’s market capitalisation of Ignyta Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ignyta Inc?
plus_minus_icon
What percentage is Ignyta Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ignyta Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$114.47
$-4.64
(-3.9%)
logo-rxdx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Lantheus Holdings
Lantheus Holdings
$55.84
$1.19 (2.18 %)
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$30.72
$-0.06 (-0.19 %)
MacroGenics, Inc.
MacroGenics, Inc.
$5.92
$-0.30 (-4.82 %)
CytomX Therapeutics Inc
CytomX Therapeutics Inc
$2.78
$0.16 (6.11 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Lantheus Holdings
Lantheus Holdings
$55.84
$1.19 (2.18 %)
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$30.72
$-0.06 (-0.19 %)
MacroGenics, Inc.
MacroGenics, Inc.
$5.92
$-0.30 (-4.82 %)
CytomX Therapeutics Inc
CytomX Therapeutics Inc
$2.78
$0.16 (6.11 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00